Precigen (PGEN) Depreciation & Amortization (CF) (2012 - 2026)

Precigen (PGEN) reported Depreciation & Amortization (CF) of $1.1 million for Q1 2026, up 74.72% year-over-year from $629000.0 in Q1 2025, and down 3.34% quarter-over-quarter from $1.1 million in Q4 2025.

Precigen (PGEN) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Depreciation & Amortization (CF) data on file, last reported at $1.1 million in Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $1.1 million, up 74.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 3.06% YoY), and the FY2025 annual result was $3.2 million, down 29.32% from the prior year.
  • Depreciation & Amortization (CF) retreated to $1.1 million in Q1 2026 per PGEN's latest filing, from $1.1 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $3.3 million in Q1 2022 and troughed at $629000.0 in Q1 2025.
  • A 5-year average of $1.4 million and a median of $1.6 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) sank 60.56% in 2025, then surged 74.72% in 2026.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.7 million in 2022, then declined by 6.22% to $1.6 million in 2023, then slumped by 59.05% to $661000.0 in 2024, then surged by 72.01% to $1.1 million in 2025, then decreased by 3.34% to $1.1 million in 2026.
  • Business Quant data shows PGEN's Depreciation & Amortization (CF) at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $803000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 1,395.22
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -1,330.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 55.90 Mn
9 Abivax 94.37 Bn 94.37 Bn - 429,663.65
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn 1.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.10 Mn
Mar 31, 2026 1.10 Mn
Dec 31, 2025 1.14 Mn
Dec 31, 2025 1.14 Mn
Sep 30, 2025 803,000.00
Sep 30, 2025 803,000.00
Jun 30, 2025 630,000.00
Jun 30, 2025 630,000.00
Mar 31, 2025 629,000.00
Mar 31, 2025 629,000.00
Dec 31, 2024 661,000.00
Dec 31, 2024 661,000.00
Sep 30, 2024 674,000.00
Sep 30, 2024 674,000.00
Jun 30, 2024 1.60 Mn
Jun 30, 2024 1.60 Mn
Mar 31, 2024 1.60 Mn
Mar 31, 2024 1.60 Mn
Dec 31, 2023 1.61 Mn
Dec 31, 2023 1.61 Mn